These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4624307)

  • 1. Pyridinolcarbamate in the treatment of ischemic heart diseases. A double blind study.
    Guzman SV
    Jpn Heart J; 1972 Jan; 13(1):53-8. PubMed ID: 4624307
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrocardiographic and hematological changes by exercise test in coronary patients and pyridinolcarbamate pretreatment. A double-blind crossover trial.
    Yamazaki H; Sano T; Odakura T; Takeuchi K; Shimamoto T
    Am Heart J; 1970 May; 79(5):640-7. PubMed ID: 4910511
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of pyridinolcarbamate on induced atherosclerosis in cynomolgus monkeys (Macaca ira).
    Malinow MR; McLaughlin P; Perley A
    Atherosclerosis; 1972; 15(1):31-6. PubMed ID: 4111120
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of the effect of pyridinolcarbamate (Anginin) on ischemic heart diseases.
    Miyahara M; Ueda T
    Jpn Heart J; 1968 Jul; 9(4):359-67. PubMed ID: 5304316
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
    Citarrella P; Abbadessa V; Pecorella M; Cajozzo A
    Boll Soc Ital Cardiol; 1977; 22(7):1036-41. PubMed ID: 618239
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of urokinase, pyridinolcarbamate, and dypiridamole in rat heart allografts.
    Ono K; Hattori T; Inokuchi K
    Surgery; 1973 Jan; 73(1):128-32. PubMed ID: 4566777
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of pyridinolcarbamate on blood coagulation and thrombolysis in patients with arteriosclerosis obliterans].
    Hess H; Goossens N; Keil-Kuri E; Zollner R; Meyer A
    Vasa; 1972; 1(3):206-11. PubMed ID: 5076123
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
    Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activity of the kallikrein-kinin system in patients with ischemic heart disease treated with parmidine].
    Vygovskiĭ VP; Zaremba EF; Podil'chak EM; Dutka RIa; Gorgota OV
    Vrach Delo; 1985 Sep; (9):6-8. PubMed ID: 2416131
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of Production on the serum lipid and lipoprotein level in ischemic heart disease].
    Orbetsov M; Orbetsova V; Todorova M; Mikhaĭlova M; Atanasova M
    Vutr Boles; 1977; 16(6):16-22. PubMed ID: 203118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion.
    Mishima Y; Kamiya K; Sakaguchi S; Kusaba A; Sakuma A
    Angiology; 1977 Feb; 28(2):84-94. PubMed ID: 326097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and electrocardiographic evaluation of the effects of nifedipine in ischemic cardiopathy with the stenocardiac syndrome].
    Mastrocola C; Baratta L; Tubani L; Vittori G; Petrosillo N; Avella A
    Boll Soc Ital Cardiol; 1978; 23(10):1721-5. PubMed ID: 122222
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.
    Motomiya T; Atsumi T; Isokane N; Yamashita S; Sano T
    Jpn Heart J; 1970 Sep; 11(5):433-49. PubMed ID: 4921577
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of a static exercise test for evaluating anti-angina effects of drugs in patients with ischemic heart disease at a polyclinic].
    Gel'fgat EB; Muradova SA; Iagizarova NM; Abdullaeva IA
    Kardiologiia; 1988 Oct; 28(10):47-51. PubMed ID: 3147339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the effects of nifedipine and nitroglycerin on the asynergic areas in chronic ischemic cardiopathy].
    Rizzon P; Franchini G; Chiddo A
    Boll Soc Ital Cardiol; 1978; (1 Suppl):98-104. PubMed ID: 120202
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
    Valiensi M; Riboli E; Lombardi M
    Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
    [No Abstract]   [Full Text] [Related]  

  • 19. Report on a double-blind investigation into the influence of -pyridyl-carbinol on the cholesterol level of the blood.
    Nelemans FA
    Arzneimittelforschung; 1972 Aug; 22(8):1410-3. PubMed ID: 4564745
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical effectiveness of depot nitroglycerin preparations in ischemic heart disease patients].
    Grigor'iants RA; Lupanov VP; Samoĭlenko LE; Lobova NM
    Ter Arkh; 1984; 56(4):67-70. PubMed ID: 6427964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.